| (R)-lipoic acid | increases expression | EXP | | 6480464 | Thioctic Acid results in increased expression of KEAP1 protein | CTD | PMID:19033392 |
| 1-chloro-2,4-dinitrobenzene | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of KEAP1 protein] | CTD | PMID:19033392 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of KEAP1 protein | CTD | PMID:19033392 |
| 1-chloro-2,4-dinitrobenzene | affects metabolic processing | ISO | RGD:733529 | 6480464 | Dinitrochlorobenzene affects the metabolism of KEAP1 protein | CTD | PMID:18785192 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733529 | 6480464 | Tetrachlorodibenzodioxin affects the expression of KEAP1 mRNA | CTD | PMID:21570461 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:621619 | 6480464 | 2,4-dinitrotoluene affects the expression of KEAP1 mRNA | CTD | PMID:21346803 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:733529 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of KEAP1 mRNA | CTD | PMID:18648102 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine affects the methylation of KEAP1 promoter] which affects the expression of KEAP1 mRNA | CTD | PMID:18555005 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of KEAP1 mRNA | CTD | PMID:20124447 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine affects the methylation of KEAP1 promoter] which affects the expression of KEAP1 mRNA | CTD | PMID:18555005 PMID:18555005 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | KEAP1 protein affects the susceptibility to Fluorouracil | CTD | PMID:18692501 |
| acrolein | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Acrolein] | CTD | PMID:19608619 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of KEAP1 mRNA | CTD | PMID:15894607 |
| amiodarone | decreases expression | ISO | RGD:621619 | 6480464 | Amiodarone results in decreased expression of KEAP1 mRNA | CTD | PMID:17991464 |
| ammonium chloride | affects expression | ISO | RGD:621619 | 6480464 | Ammonium Chloride affects the expression of KEAP1 mRNA | CTD | PMID:16483693 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of KEAP1 mRNA; more ... | CTD | PMID:14567983 |
| arsenic atom | affects response to substance | ISO | RGD:733529 | 6480464 | KEAP1 protein affects the susceptibility to Arsenic | CTD | PMID:19808700 |
| arsenic atom | affects binding | ISO | RGD:733529 | 6480464 | Arsenic binds to KEAP1 protein | CTD | PMID:19808700 |
| arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of KEAP1 protein; more ... | CTD | PMID:22476201 |
| arsenite(3-) | affects response to substance | EXP | | 6480464 | KEAP1 protein affects the susceptibility to arsenite | CTD | PMID:22476201 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | KEAP1 protein affects the reaction [arsenite results in decreased expression of NFE2L1 mRNA]; more ... | CTD | PMID:22476201 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of KEAP1 protein; more ... | CTD | PMID:22476201 |
| azathioprine | affects response to substance | ISO | RGD:733529 | 6480464 | KEAP1 protein affects the susceptibility to Azathioprine | CTD | PMID:21803983 |
| benzene-1,2,4-triol | increases expression | EXP | | 6480464 | hydroxyhydroquinone results in increased expression of KEAP1 mRNA | CTD | PMID:17572062 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of KEAP1 mRNA; more ... | CTD | PMID:20498004 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of KEAP1 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of KEAP1 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:733529 | 6480464 | Benzo(a)pyrene results in increased expression of KEAP1 mRNA | CTD | PMID:21569818 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:733529 | 6480464 | Benzo(a)pyrene results in increased expression of KEAP1 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of KEAP1 mRNA | CTD | PMID:20106945 |
| bisdemethoxycurcumin | multiple interactions | ISO | RGD:733529 | 6480464 | KEAP1 protein inhibits the reaction [bis(4-hydroxycinnamoyl)methane results in increased expression of HMOX1 mRNA] | CTD | PMID:17535857 |
| bromosulfophthalein | decreases glutathionylation | ISO | RGD:733529 | 6480464 | KEAP1 protein results in decreased glutathionylation of Sulfobromophthalein | CTD | PMID:19246623 |
| bromosulfophthalein | decreases transport | ISO | RGD:733529 | 6480464 | KEAP1 protein results in decreased transport of Sulfobromophthalein | CTD | PMID:19246623 |
| C60 fullerene | increases expression | ISO | RGD:621619 | 6480464 | fullerene C60 results in increased expression of KEAP1 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | affects binding | ISO | RGD:733529 | 6480464 | Cadmium Chloride binds to KEAP1 protein | CTD | PMID:19808700 |
| cadmium dichloride | multiple interactions | ISO | RGD:733529 | 6480464 | Cadmium Chloride affects the reaction [NFE2L2 protein binds to KEAP1 protein]; more ... | CTD | PMID:18512965 |
| cadmium dichloride | decreases expression | ISO | RGD:733529 | 6480464 | Cadmium Chloride results in decreased expression of KEAP1 mRNA | CTD | PMID:20061341 |
| carbon monoxide | multiple interactions | ISO | RGD:733529 | 6480464 | Carbon Monoxide inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | CTD | PMID:18845810 |
| chlorambucil | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil] | CTD | PMID:19608619 |
| choline | multiple interactions | ISO | RGD:733529 | 6480464 | KEAP1 affects the susceptibility to [Choline deficiency co-treated with Methionine deficiency]; more ... | CTD | PMID:20350562 |
| cisplatin | multiple interactions | EXP | | 6480464 | [KEAP1 protein results in decreased stability of NFE2L2 protein] which results in increased susceptibility to Cisplatin | CTD | PMID:20530669 |
| clofibric acid | multiple interactions | ISO | RGD:621619 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of KEAP1 mRNA | CTD | PMID:17602206 |
| cobalt atom | affects binding | ISO | RGD:733529 | 6480464 | Cobalt binds to KEAP1 protein | CTD | PMID:15865434 |
| cobalt atom | multiple interactions | ISO | RGD:733529 | 6480464 | Zinc inhibits the reaction [Cobalt binds to KEAP1 protein] | CTD | PMID:15865434 |
| curcumin | multiple interactions | ISO | RGD:733529 | 6480464 | KEAP1 protein inhibits the reaction [Curcumin results in increased expression of HMOX1 mRNA] | CTD | PMID:17535857 |
| D-glucose | multiple interactions | ISO | RGD:733529 | 6480464 | [NFE2L2 protein co-treated with KEAP1 protein] affects the abundance of Glucose | CTD | PMID:23017736 |
| demethoxycurcumin | multiple interactions | ISO | RGD:733529 | 6480464 | KEAP1 protein inhibits the reaction [demethoxycurcumin results in increased expression of HMOX1 mRNA] | CTD | PMID:17535857 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of KEAP1 mRNA | CTD | PMID:19417148 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of KEAP1 mRNA | CTD | PMID:15894607 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of KEAP1 mRNA | CTD | PMID:15894607 PMID:19417148 |
| dibutyl phthalate | decreases expression | ISO | RGD:621619 | 6480464 | Dibutyl Phthalate results in decreased expression of KEAP1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:733529 | 6480464 | Dibutyl Phthalate results in decreased expression of KEAP1 mRNA | CTD | PMID:17361019 |
| dimercaprol | affects binding | ISO | RGD:733529 | 6480464 | Dimercaprol binds to KEAP1 protein | CTD | PMID:19808700 |
| divanadium pentaoxide | decreases expression | EXP | | 6480464 | vanadium pentoxide results in decreased expression of KEAP1 mRNA | CTD | PMID:17459161 |
| elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of KEAP1 mRNA | CTD | PMID:19244175 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:733529 | 6480464 | Egtazic Acid promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein] | CTD | PMID:15865434 |
| ethylenediaminetetraacetic acid | multiple interactions | ISO | RGD:733529 | 6480464 | Edetic Acid promotes the reaction [dexamethasone 21-methanesulfonate binds to KEAP1 protein] | CTD | PMID:15865434 |
| gliclazide | multiple interactions | ISO | RGD:621619 | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA]; more ... | CTD | PMID:21439372 |
| glucose | multiple interactions | ISO | RGD:733529 | 6480464 | [NFE2L2 protein co-treated with KEAP1 protein] affects the abundance of Glucose | CTD | PMID:23017736 |
| glutathione | multiple interactions | EXP | | 6480464 | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in increased abundance of Glutathione; more ... | CTD | PMID:19608619 |
| glutathione | multiple interactions | ISO | RGD:621619 | 6480464 | Glutathione inhibits the reaction [falcarindiol binds to and results in increased alkylation of KEAP1 protein] | CTD | PMID:20026152 |
| glutathione | multiple interactions | ISO | RGD:733529 | 6480464 | Glutathione inhibits the reaction [2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene results in increased glutathionylation of KEAP1 protein] | CTD | PMID:20800667 |
| glutathione | multiple interactions | EXP | | 6480464 | [Plant Extracts results in decreased expression of KEAP1 protein] which results in increased chemical synthesis of Glutathione | CTD | PMID:21972102 |
| hydrogen peroxide | multiple interactions | ISO | RGD:733529 | 6480464 | Hydrogen Peroxide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] | CTD | PMID:15865434 |
| hypochlorous acid | increases expression | ISO | RGD:733529 | 6480464 | Hypochlorous Acid results in increased expression of KEAP1 mRNA | CTD | PMID:17980396 |
| indomethacin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]]; more ... | CTD | PMID:11909699 |
| L-methionine | multiple interactions | ISO | RGD:733529 | 6480464 | KEAP1 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CD36 mRNA]; more ... | CTD | PMID:20350562 |
| lansoprazole | increases oxidation | ISO | RGD:621619 | 6480464 | lansoprazole results in increased oxidation of KEAP1 protein | CTD | PMID:19628634 |
| lipoic acid | increases expression | EXP | | 6480464 | Thioctic Acid results in increased expression of KEAP1 protein | CTD | PMID:19033392 |
| menadione | multiple interactions | EXP | | 6480464 | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 | CTD | PMID:19608619 |
| microcystin-LR | affects binding | EXP | | 6480464 | cyanoginosin LR binds to KEAP1 protein | CTD | PMID:20722399 |
| N-acetyl-1,4-benzoquinone imine | multiple interactions | ISO | RGD:733529 | 6480464 | KEAP1 protein inhibits the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] | CTD | PMID:19246624 |
| N-acetyl-1,4-benzoquinone imine | affects metabolic processing | ISO | RGD:733529 | 6480464 | N-acetyl-4-benzoquinoneimine affects the metabolism of KEAP1 protein | CTD | PMID:18785192 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of KEAP1 protein] | CTD | PMID:19033392 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] | CTD | PMID:11909699 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621619 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of KEAP1 mRNA | CTD | PMID:17602206 |
| NADP zwitterion | affects abundance | ISO | RGD:733529 | 6480464 | KEAP1 protein affects the abundance of NADP | CTD | PMID:21775727 |
| NADP(+) | affects abundance | ISO | RGD:733529 | 6480464 | KEAP1 protein affects the abundance of NADP | CTD | PMID:21775727 |
| nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of KEAP1 protein | CTD | PMID:19033392 |
| nicotinamide | multiple interactions | ISO | RGD:621619 | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA]; more ... | CTD | PMID:21439372 |
| paclitaxel | multiple interactions | EXP | | 6480464 | [KEAP1 protein results in decreased stability of NFE2L2 protein] which results in increased susceptibility to Paclitaxel | CTD | PMID:20530669 |
| paracetamol | affects glutathionylation | ISO | RGD:733529 | 6480464 | KEAP1 protein affects the glutathionylation of Acetaminophen | CTD | PMID:19246624 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of KEAP1 mRNA | CTD | PMID:21420995 |
| paracetamol | increases response to substance | ISO | RGD:733529 | 6480464 | KEAP1 results in increased susceptibility to Acetaminophen | CTD | PMID:20404090 |
| paracetamol | affects sulfation | ISO | RGD:733529 | 6480464 | KEAP1 protein affects the sulfation of Acetaminophen | CTD | PMID:19246624 |
| paracetamol | affects glucuronidation | ISO | RGD:733529 | 6480464 | KEAP1 protein affects the glucuronidation of Acetaminophen | CTD | PMID:19246624 |
| paracetamol | multiple interactions | ISO | RGD:733529 | 6480464 | ABCC3 protein affects the reaction [KEAP1 protein affects the glucuronidation of Acetaminophen] | CTD | PMID:19246624 |
| paracetamol | decreases response to substance | ISO | RGD:733529 | 6480464 | KEAP1 gene mutant form results in decreased susceptibility to Acetaminophen | CTD | PMID:16293230 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:621619 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of KEAP1 mRNA | CTD | PMID:20621739 |
| perillyl aldehyde | multiple interactions | EXP | | 6480464 | KEAP1 protein inhibits the reaction [perillaldehyde results in increased expression of TXN mRNA] | CTD | PMID:19123792 |
| phenobarbital | multiple interactions | ISO | RGD:733529 | 6480464 | KEAP1 protein affects the reaction [Phenobarbital results in increased expression of CYP2A5 mRNA] | CTD | PMID:22859313 |
| phlorizin | increases expression | ISO | RGD:733529 | 6480464 | Phlorhizin results in increased expression of KEAP1 mRNA | CTD | PMID:22538082 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of KEAP1 mRNA | CTD | PMID:19710929 |
| potassium dichromate | multiple interactions | ISO | RGD:733529 | 6480464 | Potassium Dichromate affects the localization of and results in decreased ubiquitination of KEAP1 protein; more ... | CTD | PMID:17420218 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin results in increased metabolism of and results in increased degradation of and results in decreased expression of KEAP1 protein | CTD | PMID:17462537 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein]; more ... | CTD | PMID:21289251 |
| resveratrol | multiple interactions | ISO | RGD:621619 | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA]; more ... | CTD | PMID:21439372 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | CTD | PMID:16948474 |
| rotenone | decreases response to substance | ISO | RGD:733529 | 6480464 | KEAP1 gene mutant form results in decreased susceptibility to Rotenone | CTD | PMID:19167360 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Acrolein]; more ... | CTD | PMID:19608619 |
| selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of KEAP1 mRNA | CTD | PMID:19244175 |
| sodium dichromate | decreases expression | ISO | RGD:733529 | 6480464 | sodium bichromate results in decreased expression of KEAP1 mRNA | CTD | PMID:22155349 |
| streptozocin | multiple interactions | ISO | RGD:621619 | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA]; more ... | CTD | PMID:21439372 |
| sulforaphane | increases expression | EXP | | 6480464 | sulforafan results in increased expression of KEAP1 protein | CTD | PMID:19033392 |
| sulforaphane | multiple interactions | ISO | RGD:733529 | 6480464 | sulforafan promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] | CTD | PMID:15865434 |
| sulforaphane | multiple interactions | EXP | | 6480464 | sulforafan promotes the reaction [KEAP1 protein binds to NFE2L2 protein]; more ... | CTD | PMID:18417180 |
| sulforaphane | multiple interactions | ISO | RGD:621619 | 6480464 | sulforafan promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | CTD | PMID:22558124 |
| sulforaphane | increases response to substance | ISO | RGD:733529 | 6480464 | KEAP1 protein results in increased susceptibility to sulforafan | CTD | PMID:22558124 |
| sulforaphane | multiple interactions | EXP | | 6480464 | sulforafan promotes the reaction [NFE2L2 protein binds to KEAP1 protein] | CTD | PMID:22558124 |
| sulforaphane | increases response to substance | EXP | | 6480464 | KEAP1 protein results in increased susceptibility to sulforafan | CTD | PMID:22558124 |
| sulforaphane | increases metabolic processing | EXP | | 6480464 | sulforafan results in increased metabolism of KEAP1 protein | CTD | PMID:21391649 |
| sulforaphane | multiple interactions | EXP | | 6480464 | Iodoacetamide inhibits the reaction [sulforafan results in increased metabolism of KEAP1 protein] | CTD | PMID:21391649 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Plant Extracts] inhibits the reaction [[Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of KEAP1 protein]; more ... | CTD | PMID:21289251 |
| trans-resveratrol | multiple interactions | ISO | RGD:621619 | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of KEAP1 mRNA]; more ... | CTD | PMID:21439372 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] | CTD | PMID:16948474 |
| valproic acid | decreases expression | ISO | RGD:733529 | 6480464 | Valproic Acid results in decreased expression of KEAP1 mRNA | CTD | PMID:21427059 |
| zinc atom | multiple interactions | ISO | RGD:733529 | 6480464 | 4,4'-dipyridyl disulfide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]]; more ... | CTD | PMID:15865434 |
| zinc atom | affects binding | ISO | RGD:733529 | 6480464 | Zinc binds to KEAP1 protein | CTD | PMID:15865434 |
| zinc(0) | multiple interactions | ISO | RGD:733529 | 6480464 | 4,4'-dipyridyl disulfide promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]]; more ... | CTD | PMID:15865434 |
| zinc(0) | affects binding | ISO | RGD:733529 | 6480464 | Zinc binds to KEAP1 protein | CTD | PMID:15865434 |